Abstract:To demonstrate that the variant not described in PKD1 gene c.7292T> A, identified in four families from the Alpujarra in Granada, is the cause of autosomal dominant polycystic kidney disease (ADPKD). This variant consists of a transversion of thymine (T) by adenine (A) that at the level of the Polycystin 1 protein produces a change of leucine (Leu/L) by Glutamine (Gln/Q) in position 2431 (p.Leu2431Gln).Sociodemographic and clinical variables were registered using clinical histories, genealogical trees, ultrasounds and genetic analysis to ADPKD and healthy individuals belonging to these families in the context of segregation study.All PKD individuals carried the c.7292T> A variant in heterozygosis, whereas healthy ones did not. Among all ADPKD patients, 62.9% were women. ADPKD diagnosis was made at 29.3 ± 15.82 years, after having the first child in 64.8%. The main reasons for diagnosis were family history and hematuria episodes. The onset of renal replacement therapy (RRT) occurred at 55.8 ± 7.62 years (range 44–67), and death at 63 ± 92.2 years (range 48–76), being the cause unknown, cardiovascular and insufficiency kidney the most frequent; the median of renal survival was established at 58.5 ± 0.77 years and the median survival of patients at 67.2 ± 3.54 years. No differences in kidney and patient survivals were observed according to sex. Among deceased patients, 52.2% required RRT and 94.4% suffered from renal failure.The variant c.7292T> A in PKD1 gene is responsible for the disease, and its distribution in the Alpujarra region of Granada suggests a founder effect. In ADPKD it is necessary to perform segregation studies that help us to reclassify genetic variants, in this case from indeterminate to pathogenic.Demostrar que la variante no descrita en el gen PKD1 c.7292T> A, identificada en cuatro familias de la comarca de la Alpujarra de Granada, es la causante de poliquistosis renal autosómica dominante (PQRAD). Esta variante consiste en una sustitución transversión de timina (T) por adenina (A) que a nivel de la proteína Policistina 1 produce un cambio de leucina (Leu/L) por Glutamina (Gln/Q) en posición 2431 (p.Leu2431Gln).Registramos variables sociodemográficas y clínicas a través de la realización de historias clínicas, árboles genealógicos, ecografías y estudios genéticos a individuos afectos y sanos pertenecientes a estas familias en el contexto del estudio de segregación.Todos los individuos afectados portaban en heterocigosis la variante c.7292T> A, mientras que los individuos sanos no la portaron. En las familias estudiadas, el 62.9% eran mujeres. El diagnóstico de PQRAD se realizó a los 29.3 ± 15.82 años de edad, después de haber tenido el primer hijo en el 64,8%. Los motivos principales de diagnóstico de la enfermedad fueron antecedentes familiares y episodios de hematuria. El inicio de tratamiento renal sustitutivo (TRS) se produjo a la edad de 55.8 ± 7.62 años (rango 44–67), y el éxitus a los 63 ± 92.2 años (rango 48–76), siendo la causa desconocida, cardiovascular e insuficiencia renal las más frecuentes; la mediana de supervivencia renal se estableció a los 58.5 ± 0.77 años y la mediana de supervivencia del paciente a los 67 ± 3.54 años. No observamos diferencias en la supervivencia del riñón y del paciente según sexo. De los pacientes fallecidos, el 52.2% necesitaron TRS y el 94.4% tenían algún grado de insuficiencia renal (IR).La variante c.7292T> A en el gen PKD1 es responsable de la enfermedad, y su distribución en la comarca de la Alpujarra de Granada sugiere un efecto fundador. En PQRAD es necesario realizar estudios de segregación que ayuden a reclasificar variantes genéticas, en este caso de indeterminada a patogénica.

Putative Mutation Of Pkd1 Gene Responsible For Autosomal Dominant Polycystic Kidney Disease In A Chinese Family

A de novo PKD1 mutation in a Chinese family with autosomal dominant polycystic kidney disease

Novel Mutations of PKD Genes in Chinese Patients Suffering from Autosomal Dominant Polycystic Kidney Disease and Seeking Assisted Reproduction

Autosomal Dominant Polycystic Kidney Disease with Ectopic Unilateral Multicystic Dysplastic Kidney

A Rare Deep Intronic Mutation of PKHD1 Gene, C.8798-459 C > A, Causes Autosomal Recessive Polycystic Kidney Disease by Pseudoexon Activation

Enhancing performance of a miniaturized surface plasmon resonance sensor in the reflectance detection mode using a waveguide-coupled bimetallic chip

Identification of Novel PKD1 and PKD2 Mutations in a Chinese Population with Autosomal Dominant Polycystic Kidney Disease

Additional File 2: Figure S2. of Generation of Special Autosomal Dominant Polycystic Kidney Disease Ipscs with the Capability of Functional Kidney-Like Cell Differentiation

[Characterization of 19 novel gene mutation sites associated with autosome-dominant polycystic kidney disease]

New Mutation Associated with Polycystic Kidney Disease Type I: A Case Report

[Genetic analysis and prenatal diagnosis for a Chinese pedigree affected with Autosomal dominant polycystic kidney disease]

Pulsed dye laser densitometry using an optical delay.

PKHD1 Gene Mutation Analysis in Two Families of Perinatal Stage Autosomal Recessive Polycystic Kidney Disease

Novel mutation of the PRRT2 gene in two cases of paroxysmal kinesigenic dyskinesia: Two case reports

Refining the genetic diagnostic puzzle: A case report on a Chinese ARPKD patient with a reciprocal balanced translocation and c.2507 T > C (p.V836A) in PKHD1

Clinical Characteristics and Mutation Analysis of Three Chinese Children with Autosomal Recessive Polycystic Kidney Disease

Autosomal dominant polycystic kidney disease caused by somatic and germline mosaicism

Asian Hotspot Fabry Disease Mutation, IVS4+919G > A, Evidence for Founder Effect and Originated in Asia >800 Years Ago

A Novel Mutation Identified in PKHD1 by Targeted Exome Sequencing: Guiding Prenatal Diagnosis for an ARPKD Family.

Familial Paroxysmal Kinesigenic Dyskinesia is Associated with Mutations in the KCNA1 Gene

is a novel causative gene implicated in X-linked polycystic kidney disease